retatrutide trial news Eli Lilly's Phase 3 Results: 28.7% Weight Loss | Drug Discovery & Development posted on the topic Lilly's Retatrutide Scores Triple Trial

These include bloodstream infections and, less often, fungemia

The medications themselves aren't directly toxic to the kidneys in most people

The calories are not coming from one big dinner

This reflects the broader GLP-1 microbiome connection, in which GLP-1 regulation is tightly linked to gut barrier integrity, microbial diversity, and mucin-degrading bacteria such as Akkermansia muciniphila

Studies in rodent models have shown exactly how GLP-1RAs can reduce alcohol consumption by affecting receptors in this area of the brain

thus, it can circumvent the degradation of dipeptidyl peptidase-4 (DPP-4) and has a prolonged intravenous half-life of 30 min and a 23 h half-life after subcutaneous administration